Evaxion A (EVAX) Net Equity Issued and Repurchased (2020 - 2021)

Evaxion A (EVAX) posted Net Equity Issued and Repurchased of $27.9 million for Q3 2021, little changed on a QoQ basis from $27.9 million in Q2 2021, and up 321.08% year-over-year from $6.6 million in Q3 2020.

Evaxion A (EVAX) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends

Evaxion A's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $27.9 million for Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Evaxion A 25.44 Mn 25.44 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 27.90 Mn
Sep 30, 2021 27.90 Mn
Jun 30, 2021 27.90 Mn
Jun 30, 2021 27.90 Mn
Mar 31, 2021 27.90 Mn
Mar 31, 2021 27.90 Mn
Sep 30, 2020 6.63 Mn
Sep 30, 2020 6.63 Mn